Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015839
Chunk: 254

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 254
---
 |   |   |  3,553,834 |   |   |                11,142,362 |   |     |  5,261,192 |   |
| Loss from operations                                                       |   |                  (6,016,088 | ) |   | (3,553,834 | ) |   |               (11,142,362 | ) |     | (5,261,192 | ) |
| Other income (expense):                                                    |   |                             |   |   |            |   |   |                           |   |     |            |   |
| Interest income (expense)                                                  |   |                      40,004 |   |   |    (79,025 | ) |   |                    63,870 |   |     |    (79,025 | ) |
| Change in fair value of Debentures                                         |   |                    (200,000 | ) |   |          - |   |   |                  (200,000 | ) |     |          - |   |
| Total other income (expense)                                               |   |                    (159,996 | ) |   |    (79,025 | ) |   |                  (136,130 | ) |     |    (79,025 | ) |
| Net loss and comprehensive loss for the year                               | $ |                  (6,176,084 | ) | $ | (3,632,859 | ) | $ |               (11,278,492 | ) |     | (5,340,217 | ) |
| Net loss per share attributable to common shareholders - basic and diluted | $ |                       (0.43 | ) | $ |      (0.44 | ) | $ |                     (0.81 | ) |     |      (0.66 | ) |
| Weighted average number of common shares outstanding - basic and diluted   |   |                  14,284,261 |   |   |  8,167,993 |   |   |                13,853,305 |   |     |  8,122,333 |   |

<div align='center'>The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

F-26

MEDICUS PHARMA LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(UNAUDITED)
For the Six Months Ended June 30, 2025 and